A phase 2 study of hyper-CVAD plus ofatumumab as frontline therapy in CD20+ acute lymphoblastic leukemia (ALL): Updated results.

Authors

null

Abdul Hamid Bazarbachi

University of Texas MD Anderson Cancer Center, Houston, TX

Abdul Hamid Bazarbachi , Musa Yilmaz , Farhad Ravandi , Deborah A. Thomas , Maria Khouri , Guillermo Garcia-Manero , Rebecca S. Garris , Jorge E. Cortes , Nicholas James Short , Koji Sasaki , Ghayas C. Issa , Paul B. Koller , Tapan M. Kadia , Srdan Verstovsek , Naval Guastad Daver , Nitin Jain , Marina Konopleva , Susan Mary O'Brien , Elias Jabbour , Hagop M. Kantarjian

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Acute Leukemia

Clinical Trial Registration Number

NCT01363128

Citation

J Clin Oncol 36, 2018 (suppl; abstr 7041)

DOI

10.1200/JCO.2018.36.15_suppl.7041

Abstract #

7041

Poster Bd #

101

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Updated Results of Frontline Ofatumumab-Hyper-CVAD in Adults with CD20+ Acute Lymphoblastic Leukemia.

Updated Results of Frontline Ofatumumab-Hyper-CVAD in Adults with CD20+ Acute Lymphoblastic Leukemia.

First Author: Abhishek Maiti

Poster

2013 ASCO Quality Care Symposium

Improving the care of acute lymphocytic leukemia (ALL) at a large county hospital.

Improving the care of acute lymphocytic leukemia (ALL) at a large county hospital.

First Author: Meghan Sri Karuturi